1. Cancer-Its various types along with causes, symptoms, treatments and stages, in: cancer info guide. 2009.
2. Bookman MA, Darcy KM, Clarke-Pearson D, Boothby RA, Horowitz IR. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group. Journal of Clinical Oncology 2003; 21(2): 283-90.
3. Tai W, Mahato R, Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. Journal of Controlled Release 2010; 146(3): 264–75.
4. Olayioye MA. Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members”. Breast Cancer Research 2001; 3(6): 385-9.
5. Garcia-Solis P, Yahia EM, Morales-Tlalpan V, Diaz-Munoz M. Screening of antiproliferative effect of aqueous extracts of plant foods consumed in Mexico on the breast cancer cell line MCF-7. International Journal of Food Sciences and Nutrition 2009; 60(6): 39-46.
6. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985; 230(4730): 1132-9.
7. Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, HortobagyiGN. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2therapy and personalized medicine. Oncologist 2009; 14(4): 320-68.
8. Arteaga CL. ERBB receptors in cancer: signaling from the inside. Breast Cancer Research 2011; 13(2):304.
9. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nature reviews. Molecular Cell Biology 2001; 2(2):127-37.
10. Heppner GH, Miller FR, Shekhar PM. Nontransgeni c models of breast cancer. Breast Cancer Research 2000; 2(5): 331-4.
11. Jonkers J, Derksen PW. Modeling metastatic breast cancer in mice. Journal of Mammary Gland Biology and Neoplasia 2007; 12(2-3): 191-203.
12. Xanthopoulos JM, Romano AE, Majumdar SK. Response of Mouse Breast Cancer Cells to Anastrozole, Tamoxifen, and the Combination. Journal of Biomedicine and Biotechnology 2005; 2005(1): 10-9.
13. Duś D, Budzyński W, Radzikowski C. LL2 cell line derived from transplantable murine Lewis lung carcinoma--maintenance in vitro and growth characteristics. Archivum Immunologiae et Therapiae Experimentalis (Warsz) 1985; 33(6):817-23.
14. Hoffman J, Schirner M, Menrad A. A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate- encapsulated tumor cell. Cancer Research 1997; 57: 3847- 51.
15. Mcpherson MJ. PCR the basics from background to bench, Springer-Vergle Telos. 2003.
16. .Li R, Zheng H, Luo RC. Cloning and expression of the HER2 gene in MCF-7 cells. Di 1 jun yi da xue xue bao: Academic Journal of the First Medical College of PLA 2005; 25(10):1264-7.
17. O'Connor S, Li E, Majors BS, He L, Placone J, Baycin D, Betenbaugh MJ, Hristova K. Increased Expression of the Integral Membrane Protein ErbB2 in Chinese Hamster Ovary Cells Expressing the Anti-apoptotic Gene Bcl-xL. Protein Expression and Purification 2009; 67(1): 41–7.
18. Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation. Oncogene 2001; 20, 2101-11.
19. Xu TF, Zhang WQ, Yu H, Li D. Construction of an eukaryotic plasmid encoding HER2 and screening of a cell line stably expressing clones. Xi bao yu fen zi mian yi xue za zhi: Chinese Journal of Cellular and Molecular Immunology 2009; 25(3): 226-8.
20. Dus D, Budzynski W, Radzikowski C. LL2 cell line derived from transplantable murine Lewis lung carcinoma-maintenance in vitro and growth characteristics. Archivum Immunologiae et Therapiae Experimentalis (Warsz) 1985; 33(6): 817-23.
21. Ramírez BS, Pestana ES, Hidalgo GG, García TH, Rodríguez RP, Ullrich A, Férnandez LE. Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant. International Journal of Cancer 2006; 119(9): 2190-9.
22. Lu Y, Wei YQ, Tian L, Zhao X, Yang L, Hu B, Kan B, Wen YJ, Liu F, Deng HX, Li J,Mao YQ, Lei S, Huang MJ, Peng F, Jiang Y, Zhou H, Zhou LQ, Luo F. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. Journal of Immunology 2003: 15; 170(6): 3162-70.
23. Ghaem Maghami M. Tumor inhibitory effects of immunization with nano phage particle displaying super mimotope of EGFR on pVIII in animal model. [Dissertation]. Tarbiat Modares University: 2010.
)